Search Results - "Brugier, D"

Identification of premature cardiovascular disease using a family-based strategy: a feasibility pilot study by Charleux, P, Procopi, N, Rahoual, G, Rouanet, S, Brugier, D, Barthelemy, O, Kerneis, M, Vicaut, E, Silvain, J, Montalescot, G, Zeitouni, M

“…Abstract Background Current guidelines fail to identify and effectively prevent cardiovascular disease (CVD) in young adults. Purpose To assess the feasibility…”
Get full text

Reduced capacity of HDL to acquire free cholesterol upon lipolysis of triglyceride-rich lipoproteins reflects severity of myocardial infarction by Kontush, A., Canicio, A., Ma, F., Brugier, D., Sulman, D., Lesnik, P., Zeitouni, M., Guedeney, P., Kerneis, M., Guerin, M., Le Goff, W., Collet, J.-P., Silvain, J.

Get full text

Early versus delayed introduction of renin angiotensin aldosterone system inhibitors in cardiogenic shock by Sulman, D, Zeitouni, M, Beaupre, F, Devos, P, Procopi, N, Kerneis, M, Guedeney, P, Hammoudi, N, Rouanet, S, Brugier, D, Combes, A, Hekimian, G, Collet, J P, Montalescot, G, Silvain, J

“…Abstract Background There is currently no recommendation on the appropriate timing of introduction of renin angiotensin aldosterone system inhibitors (RAASi)…”
Get full text

Appropriate ischemic criteria for type 4a myocardial infarction: insights from the ALPHEUS trial by Roule, V, Zeitouni, M, Guedeney, P, Beygui, F, El Kasty, M, Braik, N, Bertin, B, Brugier, D, Range, G, Motovska, Z, Cayla, G, Vicaut, E, Montalescot, G, Silvain, J

“…Abstract Background Different troponin thresholds have been proposed to define periprocedural myocardial injury based on post percutaneous coronary…”
Get full text

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study by Collet, Jean-Philippe, MD, Hulot, Jean-Sébastien, MD, Pena, Anna, PhD, Villard, Eric, PhD, Esteve, Jean-Baptiste, MD, Silvain, Johanne, MD, Payot, Laurent, MD, Brugier, Delphine, PhD, Cayla, Guillaume, MD, Beygui, Farzin, MD, Bensimon, Gilbert, MD, Funck-Brentano, Christian, Prof, Montalescot, Gilles, Prof

“…Summary Background Clopidogrel and low-dose aspirin have become the mainstay oral antiplatelet regimen to prevent recurrent ischaemic events after acute…”
Get full text

P961Investigator versus Core Lab evaluation of coronary blood flow in PCI of patients in cardiogenic shock: a substudy of the CULPRIT-SHOCK trial by Zeitouni, M, Barthelemy, O, Rouanet, S, Guedeney, P, Hauguel-Moreau, M, Hage, G, Overtchouk, P, Brugier, D, Vignolles, N, Kerneis, M, Silvain, J, Collet, J P, Vicaut, E, Thiele, H, Montalescot, G

“…Abstract Background Thrombolysis In Myocardial Infarction (TIMI) flow is a prognostic factor which assessment is complex in life-threatening situations…”
Get full text

P3124Predictive value of the residual SYNTAX score following primary PCI in multivessel patients with MI-related cardiogenic shock - a CULPRIT SHOCK sub-analysis by Barthelemy, O, Rouanet, S, Brugier, D, Vignoles, N, Bertin, B, Zeitouni, M, Guedeney, P, Overtchouk, P, Hage, G, Hauguel-Moreau, M, Akin, I, Desch, S, Vicaut, E, Thiele, H, Montalescot, G

“…Abstract Background Complete revascularization (CR) – assessed by the residual SYNTAX score (rSS) – following PCI is associated with a better prognosis – in…”
Get full text

2050Impact on clinical outcome of on-treatment platelet reactivity according to concordant platelet function tests: the multi-test platelet function study by Guedeney, P., Pellaton, C., Hulot, J.S., Kerneis, M., Silvain, J., Barthelemy, O., Brugier, D., Eekhout, E., Diallo, A., Vicaut, E., Montalescot, G., Collet, J.P.

Get full text

P5400Professional status and long-term prognosis of premature coronary artery disease: the AFIJI registry by Zeitouni, M, Collet, J P, Silvain, J, Hulot, J S, Kerneis, M, Lavie-Badie, Y, Barthelemy, O, Payot, L, Esteve, J B, Lattuca, B, Galier, S, Brugier, D, Diallo, A, Vicaut, E, Montalescot, G

Get full text

P4207The natural history of premature coronary artery disease over 20 years: the AFIJI registry by Zeitouni, M, Collet, J P, Hulot, J S, Silvain, J, Kerneis, M, Lattuca, B, Barthelemy, O, Lavie-Badie, Y, Esteve, J B, Payot, L, Brugier, D, Galier, S, Diallo, A, Vicaut, E, Montalescot, G

Get full text

P6233Intima-Media thickness to better risk-stratify patients with premature coronary artery disease: an analysis from the AFUI registry by Collet, J P, Zeitouni, M, Hulot, J S, Silvain, J, Barthelemy, O, Kerneis, M, Lattuca, B, Lavie-Badie, Y, Payot, L, Esteve, J B, Brugier, D, Galier, S, Diallo, A, Vicaut, E, Montalescot, G

Get full text

Ticagrelor or prasugrel in STEMI patients: a pharmacodynamic evaluation by Kerneis, M., Abtan, J., Silvain, J., O'Connor, S. A., Barthelemy, O., Vignalou, J. B., Brugier, D., Collet, J., Montalescot, G.

Get full text

More predictable anticoagulation with intravenous enoxaparin than with unfractionated heparin in patients undergoing primary percutaneous coronary intervention: a substudy of the ATOLL trial by O'Connor, S., Kerneis, M., Ankri, A., Abtan, J., Brugier, D., Silvain, J., Ecollan, P., Vicaut, E., Collet, J. P., Montalescot, G.

Get full text

Peri-procedural thrombin generation predicts ischemic complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction: a substudy of the ATOLL trial by O'Connor, S., Ankri, A., Kerneis, M., Abtan, J., Brugier, D., Galier, S., Silvain, J., Vicaut, E., Collet, J. P., Montalescot, G.

Get full text

Restoration of platelet function with platelet transfusion in cardiac surgery patients on dual antiplatelet therapy by O'Connor, S., Rejane, M., Amour, J., Abtan, J., Kerneis, M., Silvain, J., Brugier, D., Leprince, P., Montalescot, G., Collet, J. P.

Get full text

Serum cholesterol efflux capacity and mortality in patients with acute myocardial infarction by Guerin, M., Silvain, J., Gall, J., Darabi, M., Frisdal, E., Hauguel-Moreau, M., Zeitouni, M., Kerneis, M., Lattuca, B., Brugier, D., Collet, J.P., Lesnik, P., Montalescot, G.

Get full text

Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assay by Abtan, J, Silvain, J, Kerneis, M, O'Connor, S A, Barthélémy, O, Vignalou, J-B, Beygui, F, Brugier, D, Collet, J-P, Montalescot, G

“…A new ELISA technique has been developed to measure the vasodilator-associated stimulated phosphoprotein (VASP) platelet reactivity index (PRI) in…”
Get more information

A prospective cardiometabolism ApPRoach of mechanisms of coronary plaque rupture to apprehend patients at risk of recurrent events — The APPROACH registry by Lattuca, B., Kerneis, M., Lesnik, P., Guerin, M., Legoff, W., Leroy, T., Barthelemy, O., Helft, G., Lefeuvre, C., Brugier, D., Collet, J.P., Montalescot, G., Silvain, J.

Get full text

Short-term effects of the smoke-free legislation on haemostasis and systemic inflammation due to second hand smoke exposure. The AERER study by Cayla, G, Sié, P, Silvain, J, Brugier, D, Cambou, J-P, Thomas, D, Pena, A, O'Connor, S A, Bura, A, Ruidavets, J-B, Montalescot, G, Collet, J-P

“…It was the objective of this study to assess the effect of the implementation of the smoke-free legislation on haemostasis and systemic inflammation in…”
Get more information

017 Aldosterone receptor blockade at presentation for ST elevation myocardial infarction is associated with a reduction in potentially lethal ventricular arhythmia by Labbé, Jean-Philippe, Beygui, Farzin, Bellemain-Appaix, Anne, Silvain, Johan, Barthelemy, Olivier, Brugier, D., Cayla, Cayla G., Collet, Jp, Montalescot, G.

Get full text